Access the Recap Website Here! IRVINE, CA / ACCESSWIRE / November 27, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ...

For some, the COVID-19 pandemic might feel far removed from their current day-to-day lives. But others still grapple with long-term health ramifications. After battling COVID-19, Jimmy Strohmaier was ...

The study was stopped early to allow all patients with advanced PAH the option for treatment with the activin signaling ...

Researchers have discovered that a drug commonly used to treat hypertension can extend lifespan and slow down aging. The ...

Hypertension, also known as high blood pressure, is a chronic health condition that occurs when the force of your blood pushing against the walls of your blood vessels is consistently too high. A ...

An independent data monitoring committee has recommended terminating the ZENITH study early based on the results.

In March, Winrevair became the first FDA-approved therapy for PAH that addresses the underlying mechanism behind the disease, ...

A study by St. Michael’s Hospital suggests that a common type of blood pressure medication, called angiotensin receptor ...

In recent health developments, the FDA approved a new drug by BridgeBio for a deadly heart condition. Additionally, Merck's ...

Over time, hypertension can lead to serious medical problems including stroke, heart attack, and kidney failure.

The Food and Drug Administration (FDA) has issued an advisory announcing the inclusion of additional medicines for cancer, ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...